FN Media Group Presents USA News Group News Commentary
VANCOUVER, BC, May 31, 2023 /PRNewswire/ -- USA News Group - With this year's Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there's plenty of anticipation for updates on some of the biggest developments in the world of cancer research. In the past, the event has delivered some major milestones and catalyst events for biotech companies large and small, and this year's lineup is certainly shaping up to deliver more big results. Among the announced lineup of companies that ASCO deemed worthy of an oral presentation features a wide range of players, including Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Geron Corporation (NASDAQ:GERN), IN8bio, Inc. (NASDAQ:INAB), and Veracyte, Inc. (NASDAQ:VCYT).
Read more at prnewswire.com